| Business Summary | | American
Biomed,
Inc.
develops,
manufactures
and
markets
medical,
surgical
and
diagnostic
devices,
primarily
through
its
subsidiary,
Cathlab
Corporation.
The
Company's
primary
technology
is
directed
at
interventional
cardiology,
endovascular
surgery
and
minimally
invasive
surgical
devices.
The
principal
products
are
atherectomy
catheters,
stents,
clot
filters,
100%-silicone
balloon
catheters
and
drug
delivery
catheter
systems.
The
Company's
primary
business
strategy
is
to
design
and
develop
minimally
invasive
medical
devices
to
treat
atherosclerotic
disease.
Cathlab
has
10
FDA-approved
balloon
catheters,
seven
of
which
are
currently
being
marketed
within
the
United
States
and
abroad. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | American
Biomed,
Inc.
is
a
development
stage
company
engaged
in
the
development,
manufacture
and
marketing
of
medical,
surgical
and
diagnostic
devices.
For
the
three
months
ended
3/31/00,
net
sales
fell
42%
to
$65
thousand.
Net
loss
fell
46%
to
$312
thousand.
Revenues
reflect
manufacturing
backlogs
created
from
the
relocation
of
the
manufacturing
facility.
Lower
loss
reflects
lower
selling,
general
and
administrative
costs
in
addition
to
lower
research
expense. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY1999 Pay | |
| Justine Corday, 52 Chairman,
Interim CEO | -- | Marshall Kerr, 49 Pres,
COO, Director | $108K | Colene Blankinship, 50 Sec. | -- | Dollar
amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|